US2006282907A1PendingUtilityA1
Transgenic animal having fatty acid desaturase and method of producing the same
Assignee: JAPAN SOC PROMOTION MACH INDPriority: Jan 30, 2003Filed: Jan 30, 2003Published: Dec 14, 2006
Est. expiryJan 30, 2023(expired)· nominal 20-yr term from priority
Inventors:Kazuhiro SaekiKazuya MatsumotoMikio KinoshitaIwane SuzukiYoshitomo TaguchiKoji MikamiMasatsugu UedaYoshihiro HosoiNorio MurataAkira IritaniKouichiro Kano
C12N 9/0032A01K 2227/108A01K 2267/02C12N 15/8509A01K 2227/105A01K 2267/0375A01K 67/0275A01K 2217/05C12N 9/0083A01K 2267/0362
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
To provide meat that is beneficial to human health, for the purpose to produce transgenic animals in which the content of unsaturated fatty acids increase is increased, transgenic animals characterized by increased content of unsaturated fatty acids that are beneficial to human health is provided by the present invention. Furthermore, the present invention also provides a method to enhance levels of unsaturated fatty acid in animals.
Claims
exact text as granted — not AI-modified1 . A transgenic animal in which a gene for a fatty acid desaturase is introduced into the animal to transform the animal to allow the gene for a fatty acid desaturase to be expressed in the animal, thereby the content of unsaturated fatty acid is increased in the animal.
2 . The transgenic animal according to claim 1 wherein the gene for a fatty acid desaturase is (a) genes for a Δ12 fatty acid desaturase and/or a gene for a Δ15 fatty acid desaturase.
3 . The transgenic animal according to claim 2 wherein the gene for a fatty acid desaturase is a gene for Δ12 fatty acid desaturase derived from the root of spinach.
4 . The transgenic animal according to claim 1 wherein the gene for a fatty acid desaturase is a gene for a Δ12 fatty acid desaturase derived from roots of spinach, and expression of the gene is promoted by a chicken β-actin promoter or by an adipocyte P2 (aP2) promoter.
5 . The transgenic animal according to claim 1 wherein the unsaturated fatty acid is linoleic acid, α-linolenic acid, eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA).
6 . The transgenic animal according to claim 1 wherein the animal is for a source of meat.
7 . The transgenic animal according to claim 6 wherein the animal is a mammal.
8 . The transgenic animal according to claim 7 wherein the mammal is a pig, cattle, goat or sheep.
9 . A transgenic animal cell in which a gene for a fatty acid desaturase is introduced into the animal cell to transform the animal cell to allow the gene for a fatty acid desaturase to be expressed in the animal cell, thereby the content of unsaturated fatty acid is increased in the animal cell.
10 . A method for increasing the content of unsaturated fatty acids in an animal, the method comprising the steps of introducing a gene for fatty acid desaturase in an animal, and transforming the animal to allow the gene for fatty acid desaturase to be expressed in the animal.
11 . A method for increasing the content of unsaturated fatty acids in an animal, the method comprising the steps of constructing a vector containing a gene for a fatty acid desaturase with a transcriptional control region that enables expression of the gene for fatty acid desaturase, transforming animals by introduction of the vector into early embryos, somatic cells or embryonic stem cells (ES cells) of the animals, and allowing the gene for a fatty acid desaturase to be expressed in the animals that were developed from the transformed early embryos, somatic cells or embryonic stem cells.
12 . The method according to claim 10 wherein the gene for a fatty acid desaturase is a gene for a Δ12 fatty acid desaturase and/or a gene for a Δ15 fatty acid desaturase.
13 . The method according to claim 12 wherein the gene for a fatty acid desaturase is a gene for a Δ12 fatty acid desaturase derived from roots of spinach.
14 . The method according to claim 11 wherein the gene for a fatty acid desaturase is a gene for Δ12 fatty acid desaturase derived from the root of spinach, and the transcriptional control region is a chicken β-actin promoter or an adipocyte P2 (aP2) promoter.
15 . The method according to claim 10 wherein the unsaturated fatty acid is linoleic acid, α-linolenic acid, eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA).Join the waitlist — get patent alerts
Track US2006282907A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.